Purple Urine Bag Syndrome (PUBS) is a rare clinical phenomenon typically seen in elderly female patients. It occurs in patients who have chronic urethral catheterisation and comorbid conditions such as chronic urinary tract infections, immobility (bedridden or wheelchair-bound), dehydration, constipation, and chronic kidney disease. The pathophysiology of PUBS is thought to develop as a result of the complex metabolic pathway of essential amino acid tryptophan in the gastrointestinal system, forming urine metabolites converted by bacterial enzymes, sulphatase and phosphatase, turning urine bag and tubing purple. PUBS can emerge as asymptomatic bacteriuria or symptomatic urinary tract infection in a patient with an indwelling urinary catheter. This case report uniquely describes an elderly patient who had a prolonged urethral catheter and presented with a purple discolouration of the urine collection bag with acidic urine and a startling Klebsiella ozaenae species that has not been reported to cause this phenomenon before. In many literatures, it is noted to be a benign condition; however, it carries a significant morbidity and mortality. Thereupon, it is critical to vigilantly screen chronic catheterised patients and manage them accordingly. Management of PUBS includes: targeted antibiotic therapy, correcting underlying predisposing factors, aseptic changing of urethral catheter, and finally calming patient and caregivers regarding the condition.
Published in | International Journal of Medical Case Reports (Volume 4, Issue 3) |
DOI | 10.11648/j.ijmcr.20250403.11 |
Page(s) | 42-46 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Purple Urine Bag Syndrome, PUBS, Urinary Tract Infections, Klebsiella Spp, Tryptophan Metabolism, Catheter-associated UTI, Elderly Care
Antibiotic | Sensitivity |
---|---|
Ciprofloxacin | R |
Trimethoprim/Sulphamethoxazol | R |
Amikacin | S |
Gentamycin | R |
Ceftriaxone | R |
Ceftriaxone sulbactam | I |
Nitrofurantoin | R |
Piperacillin /tazobactam | S |
Ceftazidime | R |
Meropenem | S |
Cefepime | R |
Amoxylin/clavunic acid | R |
PUBS | Purple Urine Bag Syndrome |
UTI | Urinary Tract Infection |
ESRD | End Stage Renal Disease |
BPH | Benign Prostate Hyperplasia |
e-GFR | Estimated Glomerular Filtration Rate |
R | Resistant |
S | Sensitive |
I | Intermediate |
[1] | Y. Hadano, T. Shimizu, S. Takada, T. Inoue, and S. Sorano, “An update on purple urine bag syndrome,” Int J Gen Med, vol. 5, pp. 707-710, Aug. 2012, |
[2] | G. B. Barlow and J. a. S. Dickson, “PURPLE URINE BAGS,” The Lancet, vol. 311, no. 8057, pp. 220-221, Jan. 1978, |
[3] | V. K. Neniwal, S. Swain, S. K. Rulaniya, D. Hota, P. Agarwal, and P. K. Yadav, “Purple urine bag syndrome: An unusual manifestation of urinary tract infection, our experience at a tertiary care center,” Current Urology, vol. 17, no. 2, p. 125, Jun. 2023, |
[4] | H.-W. Yang and Y.-J. Su, “Trends in the epidemiology of purple urine bag syndrome: A systematic review,” Biomed Rep, vol. 8, no. 3, pp. 249-256, Mar. 2018, |
[5] | D. Bar-Or, L. T. Rael, R. Bar-Or, M. L. Craun, J. Statz, and R. E. Garrett, “Mass spectrometry analysis of urine and catheter of a patient with purple urinary bag syndrome,” Clinica Chimica Acta, vol. 378, no. 1, pp. 216-218, Mar. 2007, |
[6] | S.-D. Chung, C.-H. Liao, and H.-D. Sun, “Purple urine bag syndrome with acidic urine,” Int J Infect Dis, vol. 12, no. 5, pp. 526-527, Sep. 2008, |
[7] | B. P. Traynor, E. Pomeroy, and D. Niall, “Purple urine bag syndrome: a case report and review of the literature,” Oxf Med Case Reports, vol. 2017, no. 11, p. omx059, Nov. 2017, |
[8] | M. B. Popović, D. D. Medić, R. S. Velicki, and A. I. Jovanović Galović, “Purple Urine Bag Syndrome in a Home-Dwelling Elderly Female with Lumbar Compression Fracture: A Case Report,” Healthcare, vol. 11, no. 16, Art. no. 16, Jan. 2023, |
[9] | U. Kumar, A. Singh, G. Thami, and N. Agrawal, “Purple urine bag syndrome: A simple and rare spot diagnosis in Uroscopic rainbow,” Urology Case Reports, vol. 35, p. 101533, Mar. 2021, |
[10] | P. D. M. de M. Neves, B. M. C. Ferreira, S. Mohrbacher, P. R. Chocair, and A. L. Cuvello-Neto, “Purple urine bag syndrome: a colourful complication of urinary tract infection,” The Lancet Infectious Diseases, vol. 20, no. 10, p. 1215, Oct. 2020, |
[11] | Y.-J. Su and H.-W. Yang, “Risk factors of mortality in patients with purple urine bag syndrome,” J Drug Assess, vol. 8, no. 1, pp. 21-24, Feb. 2019, |
[12] | L. Kannan and A. A. Bauman, “Purple urine in a patient with UTI and constipation,” Oxford Medical Case Reports, vol. 2023, no. 2, p. omad013, Feb. 2023, |
[13] | M. Kılıç et al., “Purple Urine Bag Syndrome: A Case Report,” Global Emergency And Critical Care, Aug. 2023, |
[14] | M. Oliveira Rodríguez, M. Moreno Rodríguez, J. J. Díaz Martín, and B. Prieto García, “Purple urine in Berdon syndrome: a rare finding in the clinic laboratory,” Ann Clin Biochem, vol. 60, no. 2, pp. 142-145, Mar. 2023, |
[15] | P. K, P. A, and K. Sp, “Purple urine bag syndrome in catheter associated urinary tract infection: A case report,” J Med Sci Res., vol. 10, no. 1, pp. 39-41, Jan. 2022, |
[16] | D. S. Kalsi, J. Ward, R. Lee, and A. Handa, “Purple Urine Bag Syndrome: A Rare Spot Diagnosis,” Disease Markers, vol. 2017, no. 1, p. 9131872, 2017, |
[17] | N. Sabanis, E. Paschou, P. Papanikolaou, and G. Zagkotsis, “Purple Urine Bag Syndrome: More Than Eyes Can See,” Curr Urol, vol. 13, no. 3, pp. 125-132, Nov. 2019, |
APA Style
Sandhu, P., Suleman, S., Suleman, H. (2025). Case Report: Purple Urine Bag Syndrome with Surprisingly Acidic Urine. International Journal of Medical Case Reports, 4(3), 42-46. https://doi.org/10.11648/j.ijmcr.20250403.11
ACS Style
Sandhu, P.; Suleman, S.; Suleman, H. Case Report: Purple Urine Bag Syndrome with Surprisingly Acidic Urine. Int. J. Med. Case Rep. 2025, 4(3), 42-46. doi: 10.11648/j.ijmcr.20250403.11
@article{10.11648/j.ijmcr.20250403.11, author = {Paramjeet Sandhu and Shahzmah Suleman and Hamisi Suleman}, title = {Case Report: Purple Urine Bag Syndrome with Surprisingly Acidic Urine }, journal = {International Journal of Medical Case Reports}, volume = {4}, number = {3}, pages = {42-46}, doi = {10.11648/j.ijmcr.20250403.11}, url = {https://doi.org/10.11648/j.ijmcr.20250403.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmcr.20250403.11}, abstract = {Purple Urine Bag Syndrome (PUBS) is a rare clinical phenomenon typically seen in elderly female patients. It occurs in patients who have chronic urethral catheterisation and comorbid conditions such as chronic urinary tract infections, immobility (bedridden or wheelchair-bound), dehydration, constipation, and chronic kidney disease. The pathophysiology of PUBS is thought to develop as a result of the complex metabolic pathway of essential amino acid tryptophan in the gastrointestinal system, forming urine metabolites converted by bacterial enzymes, sulphatase and phosphatase, turning urine bag and tubing purple. PUBS can emerge as asymptomatic bacteriuria or symptomatic urinary tract infection in a patient with an indwelling urinary catheter. This case report uniquely describes an elderly patient who had a prolonged urethral catheter and presented with a purple discolouration of the urine collection bag with acidic urine and a startling Klebsiella ozaenae species that has not been reported to cause this phenomenon before. In many literatures, it is noted to be a benign condition; however, it carries a significant morbidity and mortality. Thereupon, it is critical to vigilantly screen chronic catheterised patients and manage them accordingly. Management of PUBS includes: targeted antibiotic therapy, correcting underlying predisposing factors, aseptic changing of urethral catheter, and finally calming patient and caregivers regarding the condition.}, year = {2025} }
TY - JOUR T1 - Case Report: Purple Urine Bag Syndrome with Surprisingly Acidic Urine AU - Paramjeet Sandhu AU - Shahzmah Suleman AU - Hamisi Suleman Y1 - 2025/07/16 PY - 2025 N1 - https://doi.org/10.11648/j.ijmcr.20250403.11 DO - 10.11648/j.ijmcr.20250403.11 T2 - International Journal of Medical Case Reports JF - International Journal of Medical Case Reports JO - International Journal of Medical Case Reports SP - 42 EP - 46 PB - Science Publishing Group SN - 2994-7049 UR - https://doi.org/10.11648/j.ijmcr.20250403.11 AB - Purple Urine Bag Syndrome (PUBS) is a rare clinical phenomenon typically seen in elderly female patients. It occurs in patients who have chronic urethral catheterisation and comorbid conditions such as chronic urinary tract infections, immobility (bedridden or wheelchair-bound), dehydration, constipation, and chronic kidney disease. The pathophysiology of PUBS is thought to develop as a result of the complex metabolic pathway of essential amino acid tryptophan in the gastrointestinal system, forming urine metabolites converted by bacterial enzymes, sulphatase and phosphatase, turning urine bag and tubing purple. PUBS can emerge as asymptomatic bacteriuria or symptomatic urinary tract infection in a patient with an indwelling urinary catheter. This case report uniquely describes an elderly patient who had a prolonged urethral catheter and presented with a purple discolouration of the urine collection bag with acidic urine and a startling Klebsiella ozaenae species that has not been reported to cause this phenomenon before. In many literatures, it is noted to be a benign condition; however, it carries a significant morbidity and mortality. Thereupon, it is critical to vigilantly screen chronic catheterised patients and manage them accordingly. Management of PUBS includes: targeted antibiotic therapy, correcting underlying predisposing factors, aseptic changing of urethral catheter, and finally calming patient and caregivers regarding the condition. VL - 4 IS - 3 ER -